| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.744 | 0.019 | 0.744 | Caspase 9 stimulant | 0.256 0.245 CID_154699584 | ||
| 0.651 | 0.008 | 0.651 | Caspase 3 stimulant | |||
| 0.607 | 0.018 | 0.607 | Aldehyde oxidase inhibitor | |||
| 0.59 | 0.051 | 0.59 | Apoptosis agonist | 0.279 0.188 CID_154699584 | ||
| 0.581 | 0.059 | 0.627 | Antiinflammatory | 0.627 0.046 CID_154699584 | CID_154699584 | |
| 0.479 | 0.037 | 0.479 | Histamine release inhibitor | 0.458 0.046 CID_154699584 | ||
| 0.487 | 0.046 | 0.487 | Transcription factor NF kappa B inhibitor | 0.311 0.089 CID_154699584 | ||
| 0.429 | 0.03 | 0.429 | Antioxidant | 0.407 0.034 CID_154699584 | ||
| 0.386 | 0.009 | 0.386 | NOS3 expression enhancer | 0.22 0.034 CID_154699584 | ||
| 0.393 | 0.03 | 0.393 | DNA damaging | 0.179 0.135 CID_154699584 | ||
| 0.368 | 0.008 | 0.368 | Neurotrophic factor enhancer | 0.152 0.135 CID_154699584 | ||
| 0.386 | 0.034 | 0.386 | Hypoxia-inducible factor 1 alpha inhibitor | 0.212 0.138 CID_154699584 | ||
| 0.376 | 0.028 | 0.376 | Nitric oxide antagonist | 0.177 0.078 CID_154699584 | ||
| 0.406 | 0.06 | 0.406 | Immunosuppressant | 0.333 0.096 CID_154699584 | ||
| 0.377 | 0.034 | 0.377 | Calcium channel activator | 0.236 0.164 CID_154699584 | ||
| 0.351 | 0.012 | 0.351 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.368 | 0.029 | 0.368 | Vasodilator | |||
| 0.385 | 0.06 | 0.385 | Vasodilator, peripheral | |||
| 0.348 | 0.024 | 0.348 | Anesthetic general | |||
| 0.37 | 0.052 | 0.37 | 5 Hydroxytryptamine release stimulant | |||
| 0.395 | 0.081 | 0.395 | 5 Hydroxytryptamine release inhibitor | |||
| 0.345 | 0.043 | 0.345 | Sodium/bile acid cotransporter inhibitor | 0.289 0.089 CID_154699584 | ||
| 0.311 | 0.02 | 0.311 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.372 | 0.09 | 0.443 | Antibacterial | 0.443 0.059 CID_154699584 | CID_154699584 | |
| 0.378 | 0.097 | 0.378 | Calcium channel L-type activator | |||
| 0.301 | 0.021 | 0.301 | Lipocortins synthesis antagonist | 0.134 0.132 CID_154699584 | ||
| 0.312 | 0.037 | 0.312 | Sigma receptor agonist | |||
| 0.311 | 0.047 | 0.455 | Superoxide dismutase inhibitor | 0.455 0.018 CID_154699584 | CID_154699584 | |
| 0.333 | 0.072 | 0.557 | Cholesterol antagonist | 0.557 0.024 CID_154699584 | CID_154699584 | |
| 0.302 | 0.043 | 0.302 | DNA synthesis inhibitor | 0.187 0.143 CID_154699584 | ||
| 0.274 | 0.016 | 0.274 | Adenylate cyclase inhibitor | |||
| 0.295 | 0.044 | 0.295 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.289 | 0.039 | 0.289 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.254 | 0.005 | 0.254 | MAP3K9 inhibitor | 0.187 0.022 CID_154699584 | ||
| 0.251 | 0.006 | 0.251 | Estrogen receptor alpha antagonist | 0.071 0.066 CID_154699584 | ||
| 0.289 | 0.051 | 0.289 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.33 | 0.097 | 0.33 | GABA C receptor rho-3 antagonist | |||
| 0.237 | 0.009 | 0.237 | Estrogen antagonist | 0.107 0.082 CID_154699584 | ||
| 0.244 | 0.017 | 0.244 | Alkylator | 0.177 0.034 CID_154699584 | ||
| 0.242 | 0.016 | 0.242 | ATPase inhibitor | |||
| 0.226 | 0.007 | 0.303 | Estrogen agonist | 0.303 0.005 CID_154699584 | CID_154699584 | |
| 0.291 | 0.073 | 0.291 | Spasmolytic | 0.19 0.129 CID_154699584 | ||
| 0.221 | 0.007 | 0.222 | Adenylate cyclase stimulant | 0.222 0.007 CID_154699584 | CID_154699584 | |
| 0.255 | 0.042 | 0.255 | Growth hormone agonist | |||
| 0.276 | 0.066 | 0.276 | Transcription factor STAT3 inhibitor | |||
| 0.254 | 0.047 | 0.423 | RNA-directed DNA polymerase inhibitor | 0.423 0.016 CID_154699584 | CID_154699584 | |
| 0.277 | 0.069 | 0.277 | Transcription factor STAT inhibitor | |||
| 0.218 | 0.018 | 0.218 | Arachidonic acid antagonist | 0.151 0.087 CID_154699584 | ||
| 0.206 | 0.009 | 0.206 | Estrogen receptor beta antagonist | 0.098 0.068 CID_154699584 | ||
| 0.202 | 0.005 | 0.202 | Transcription factor AP-1 inhibitor | 0.06 0.045 CID_154699584 | ||
| 0.201 | 0.01 | 0.201 | Creatine kinase inhibitor | 0.106 0.053 CID_154699584 | ||
| 0.207 | 0.023 | 0.207 | Cystathionine beta-synthase inhibitor | |||
| 0.231 | 0.048 | 0.231 | P-glycoprotein inhibitor | |||
| 0.213 | 0.03 | 0.213 | Topoisomerase II inhibitor | 0.114 0.072 CID_154699584 | ||
| 0.202 | 0.021 | 0.202 | Antineoplastic antibiotic | 0.105 0.044 CID_154699584 | ||
| 0.193 | 0.013 | 0.193 | Pregnane X receptor agonist | 0.165 0.032 CID_154699584 | ||
| 0.255 | 0.075 | 0.255 | Interleukin agonist | |||
| 0.192 | 0.013 | 0.192 | HIV-1 integrase (Overall Integration) inhibitor | 0.129 0.034 CID_154699584 | ||
| 0.183 | 0.005 | 0.183 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.194 | 0.016 | 0.194 | MAP kinase kinase 4 inhibitor | |||
| 0.191 | 0.015 | 0.191 | Photosensitizer | 0.114 0.065 CID_154699584 | ||
| 0.194 | 0.019 | 0.194 | UDP-glucose 4-epimerase inhibitor | |||
| 0.212 | 0.037 | 0.246 | Phospholipase C inhibitor | 0.246 0.026 CID_154699584 | CID_154699584 | |
| 0.244 | 0.07 | 0.244 | Hypolipemic | |||
| 0.174 | 0.009 | 0.192 | Anabolic | 0.192 0.005 CID_154699584 | CID_154699584 | |
| 0.173 | 0.01 | 0.173 | Ca2+-transporting ATPase inhibitor | |||
| 0.311 | 0.153 | 0.311 | Cyclophilin D inhibitor | |||
| 0.197 | 0.042 | 0.197 | Melanin inhibitor | |||
| 0.33 | 0.175 | 0.33 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.166 | 0.015 | 0.166 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.072 0.059 CID_154699584 | ||
| 0.184 | 0.033 | 0.184 | DNA polymerase I inhibitor | |||
| 0.16 | 0.009 | 0.16 | Alcohol oxidase inhibitor | |||
| 0.232 | 0.084 | 0.232 | Tumour necrosis factor alpha release inhibitor | 0.223 0.091 CID_154699584 | ||
| 0.206 | 0.061 | 0.214 | Hepatoprotectant | 0.214 0.057 CID_154699584 | CID_154699584 | |
| 0.238 | 0.094 | 0.238 | Gastrin inhibitor | |||
| 0.256 | 0.113 | 0.256 | Interleukin 2 agonist | |||
| 0.201 | 0.059 | 0.201 | Peroxidase inhibitor | |||
| 0.161 | 0.02 | 0.161 | Androgen antagonist | |||
| 0.189 | 0.048 | 0.189 | Interleukin 6 antagonist | |||
| 0.158 | 0.019 | 0.158 | Prolactin inhibitor | |||
| 0.177 | 0.039 | 0.177 | CF transmembrane conductance regulator agonist | |||
| 0.171 | 0.035 | 0.277 | Cholesterol synthesis inhibitor | 0.277 0.014 CID_154699584 | CID_154699584 | |
| 0.157 | 0.022 | 0.157 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.157 | 0.022 | 0.302 | NMDA receptor antagonist | 0.302 0.006 CID_154699584 | CID_154699584 | |
| 0.145 | 0.011 | 0.145 | Glutamate release inhibitor | |||
| 0.164 | 0.031 | 0.164 | Microtubule formation inhibitor | |||
| 0.194 | 0.061 | 0.194 | Amyloid beta precursor protein antagonist | |||
| 0.139 | 0.006 | 0.139 | Progesterone antagonist | |||
| 0.18 | 0.049 | 0.18 | Hexokinase inhibitor | |||
| 0.14 | 0.01 | 0.211 | Glycine receptor antagonist | 0.211 0.003 CID_154699584 | CID_154699584 | |
| 0.254 | 0.124 | 0.254 | Apoptosis antagonist | |||
| 0.181 | 0.051 | 0.181 | Amylase inhibitor | |||
| 0.227 | 0.098 | 0.227 | Cardiotonic | |||
| 0.154 | 0.026 | 0.154 | Antineoplastic alkaloid | |||
| 0.157 | 0.029 | 0.157 | Bronchodilator | |||
| 0.163 | 0.037 | 0.163 | DNA intercalator | 0.096 0.077 CID_154699584 | ||
| 0.135 | 0.009 | 0.135 | Glycine receptor agonist | 0.07 0.054 CID_154699584 | ||
| 0.152 | 0.027 | 0.152 | AMP-activated protein kinase stimulant | |||
| 0.153 | 0.033 | 0.153 | GABA C receptor agonist | |||
| 0.126 | 0.007 | 0.126 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.075 0.019 CID_154699584 | ||
| 0.121 | 0.003 | 0.121 | Adenylate cyclase 1 inhibitor | |||
| 0.17 | 0.057 | 0.17 | Interferon gamma antagonist | |||
| 0.222 | 0.108 | 0.372 | Immunostimulant | 0.372 0.058 CID_154699584 | CID_154699584 | |
| 0.128 | 0.015 | 0.128 | ATPase (Vacuolar H+) inhibitor | |||
| 0.123 | 0.01 | 0.133 | Androgen agonist | 0.133 0.009 CID_154699584 | CID_154699584 | |
| 0.141 | 0.028 | 0.141 | Sphingomyelinase inhibitor | |||
| 0.128 | 0.016 | 0.128 | Aromatase inhibitor | 0.063 0.039 CID_154699584 | ||
| 0.264 | 0.154 | 0.264 | 15-Lipoxygenase inhibitor | 0.217 0.195 CID_154699584 | ||
| 0.119 | 0.009 | 0.12 | Estrogen receptor beta agonist | 0.12 0.009 CID_154699584 | CID_154699584 | |
| 0.171 | 0.062 | 0.171 | Cholinergic | |||
| 0.162 | 0.053 | 0.162 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.188 | 0.081 | 0.188 | Non-steroidal antiinflammatory agent | |||
| 0.24 | 0.134 | 0.475 | Antithrombotic | 0.475 0.033 CID_154699584 | CID_154699584 | |
| 0.156 | 0.052 | 0.156 | Acetylcholinesterase inhibitor | |||
| 0.146 | 0.043 | 0.146 | Topoisomerase I inhibitor | |||
| 0.269 | 0.168 | 0.269 | MAP kinase kinase 6 inhibitor | |||
| 0.166 | 0.064 | 0.347 | Diuretic | 0.347 0.017 CID_154699584 | CID_154699584 | |
| 0.127 | 0.028 | 0.327 | Protein kinase C zeta inhibitor | 0.327 0.005 CID_154699584 | CID_154699584 | |
| 0.106 | 0.008 | 0.106 | Estrogen receptor alpha agonist | |||
| 0.124 | 0.027 | 0.124 | Histamine N-methyltransferase inhibitor | |||
| 0.126 | 0.029 | 0.208 | Triose-phosphate isomerase inhibitor | 0.208 0.01 CID_154699584 | CID_154699584 | |
| 0.157 | 0.064 | 0.157 | Protein kinase stimulant | |||
| 0.098 | 0.006 | 0.098 | Calcium channel P-type blocker | |||
| 0.171 | 0.079 | 0.171 | Succinate dehydrogenase inhibitor | |||
| 0.128 | 0.037 | 0.128 | Adenylate kinase inhibitor | |||
| 0.12 | 0.029 | 0.12 | NADH dehydrogenase inhibitor | |||
| 0.128 | 0.037 | 0.128 | DOPA decarboxylase inhibitor | |||
| 0.136 | 0.046 | 0.136 | DNA repair enzyme inhibitor | |||
| 0.133 | 0.043 | 0.133 | Protein kinase C gamma inhibitor | |||
| 0.237 | 0.147 | 0.237 | Vasodilator, coronary | |||
| 0.194 | 0.107 | 0.194 | Peptidyltransferase inhibitor | |||
| 0.109 | 0.024 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 CID_154699584 | CID_154699584 | |
| 0.15 | 0.065 | 0.15 | Mannose-6-phosphate isomerase inhibitor | |||
| 0.096 | 0.012 | 0.096 | Glutamate (mGluR6) antagonist | |||
| 0.179 | 0.097 | 0.179 | MAP kinase kinase 2 inhibitor | |||
| 0.111 | 0.029 | 0.113 | Bile acid receptor antagonist | 0.113 0.027 CID_154699584 | CID_154699584 | |
| 0.11 | 0.028 | 0.11 | Phosphofructokinase-1 inhibitor | |||
| 0.12 | 0.039 | 0.12 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | |||
| 0.139 | 0.059 | 0.186 | Glutamate receptor antagonist | 0.186 0.03 CID_154699584 | CID_154699584 | |
| 0.089 | 0.01 | 0.089 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.101 | 0.024 | 0.101 | Estrogen-related receptor beta agonist | |||
| 0.113 | 0.038 | 0.113 | Glutamate (mGluR7) agonist | |||
| 0.086 | 0.012 | 0.086 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.15 | 0.078 | 0.337 | Protein-tyrosine phosphatase inhibitor | 0.337 0.014 CID_154699584 | CID_154699584 | |
| 0.192 | 0.12 | 0.192 | Hypoglycemic | |||
| 0.091 | 0.021 | 0.091 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.216 | 0.146 | 0.216 | Immunomodulator | |||
| 0.091 | 0.023 | 0.091 | Carbamoyl phosphate synthetase inhibitor | |||
| 0.095 | 0.028 | 0.095 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.129 | 0.062 | 0.129 | Aldehyde dehydrogenase inhibitor | |||
| 0.155 | 0.089 | 0.155 | Antipruritic | |||
| 0.09 | 0.024 | 0.09 | MAP kinase kinase 7 inhibitor | |||
| 0.077 | 0.012 | 0.084 | Alpha-mannosidase inhibitor | 0.084 0.01 CID_154699584 | CID_154699584 | |
| 0.099 | 0.034 | 0.099 | mTOR complex 2 inhibitor | |||
| 0.08 | 0.016 | 0.08 | Glucosylceramidase inhibitor | |||
| 0.165 | 0.102 | 0.165 | Death-associated protein kinase 3 inhibitor | |||
| 0.081 | 0.02 | 0.081 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | |||
| 0.176 | 0.117 | 0.176 | Aryl hydrocarbon receptor agonist | |||
| 0.121 | 0.062 | 0.186 | Protein-tyrosine phosphatase 1B inhibitor | 0.186 0.033 CID_154699584 | CID_154699584 | |
| 0.142 | 0.083 | 0.142 | Heat shock protein 90 antagonist | |||
| 0.111 | 0.053 | 0.111 | Toll-Like receptor 4 antagonist | |||
| 0.066 | 0.01 | 0.066 | Dopamine D5 agonist | |||
| 0.08 | 0.025 | 0.08 | Argininosuccinate synthase inhibitor | |||
| 0.068 | 0.013 | 0.068 | Glucose-6-phosphate isomerase inhibitor | |||
| 0.133 | 0.078 | 0.133 | Farnesoid X receptor antagonist | |||
| 0.166 | 0.112 | 0.166 | Insulin sensitizer | |||
| 0.138 | 0.084 | 0.138 | Heat shock protein 70 antagonist | |||
| 0.073 | 0.019 | 0.073 | Sphingosine kinase 2 inhibitor | |||
| 0.142 | 0.088 | 0.142 | Cyclin-dependent kinase 8 inhibitor | |||
| 0.125 | 0.072 | 0.125 | Cyclooxygenase 3 inhibitor | |||
| 0.09 | 0.037 | 0.09 | Keratolytic | |||
| 0.139 | 0.087 | 0.139 | MAP kinase 3 inhibitor | |||
| 0.18 | 0.128 | 0.18 | Nitric-oxide synthase stimulant | |||
| 0.088 | 0.038 | 0.284 | NMDA 2 receptor antagonist | 0.284 0.005 CID_154699584 | CID_154699584 | |
| 0.064 | 0.014 | 0.071 | Mannosidase inhibitor | 0.071 0.011 CID_154699584 | CID_154699584 | |
| 0.084 | 0.034 | 0.084 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.065 | 0.016 | 0.065 | Aldosterone antagonist | |||
| 0.079 | 0.03 | 0.079 | Beta tubulin antagonist | |||
| 0.111 | 0.063 | 0.111 | GABA C receptor antagonist | |||
| 0.088 | 0.041 | 0.088 | T cell inhibitor | |||
| 0.08 | 0.034 | 0.096 | Phospholipase D inhibitor | 0.096 0.017 CID_154699584 | CID_154699584 | |
| 0.053 | 0.007 | 0.053 | Vanilloid 3 antagonist | |||
| 0.193 | 0.147 | 0.193 | Lipoxygenase inhibitor | |||
| 0.156 | 0.111 | 0.156 | Psychostimulant | |||
| 0.069 | 0.025 | 0.069 | Alpha tubulin antagonist | |||
| 0.064 | 0.02 | 0.064 | Topoisomerase II beta inhibitor | |||
| 0.106 | 0.062 | 0.106 | Expectorant | |||
| 0.05 | 0.007 | 0.05 | Estradiol 17 beta-dehydrogenase 1 inhibitor | |||
| 0.086 | 0.043 | 0.091 | Interferon agonist | 0.091 0.037 CID_154699584 | CID_154699584 | |
| 0.156 | 0.113 | 0.156 | I kappa B kinase epsilon inhibitor | |||
| 0.057 | 0.014 | 0.057 | Liver X receptor alpha agonist | |||
| 0.065 | 0.023 | 0.065 | Dopamine transporter inhibitor | |||
| 0.069 | 0.026 | 0.069 | Sphingosine kinase inhibitor | 0.061 0.037 CID_154699584 | ||
| 0.058 | 0.015 | 0.058 | Geranyltranstransferase inhibitor | |||
| 0.071 | 0.029 | 0.071 | Dopamine uptake inhibitor | |||
| 0.075 | 0.034 | 0.075 | 5 Hydroxytryptamine 7 antagonist | |||
| 0.072 | 0.031 | 0.131 | NMDA 2C receptor antagonist | 0.131 0.009 CID_154699584 | CID_154699584 | |
| 0.049 | 0.008 | 0.049 | Ceramide glucosyltransferase inhibitor | 0.041 0.015 CID_154699584 | ||
| 0.053 | 0.013 | 0.053 | RNA-directed RNA polymerase stimulant | |||
| 0.071 | 0.031 | 0.071 | Prostaglandin F2 alpha antagonist | |||
| 0.065 | 0.027 | 0.065 | Lipocortins synthesis agonist | |||
| 0.092 | 0.054 | 0.092 | Ornithine decarboxylase inhibitor | |||
| 0.052 | 0.015 | 0.052 | Alpha 1d adrenoreceptor agonist | |||
| 0.095 | 0.058 | 0.095 | Alcohol dehydrogenase inhibitor | |||
| 0.07 | 0.032 | 0.07 | Biliverdin reductase inhibitor | |||
| 0.039 | 0.002 | 0.039 | Thromboxane A2 agonist | |||
| 0.08 | 0.044 | 0.08 | Glutamate dehydrogenase inhibitor | |||
| 0.165 | 0.128 | 0.165 | Antiamyloidogenic | |||
| 0.044 | 0.008 | 0.044 | Estrogen-related receptor beta antagonist | |||
| 0.099 | 0.063 | 0.099 | GABA C receptor rho-1 antagonist | |||
| 0.124 | 0.09 | 0.124 | Nav1.6 sodium channel blocker | |||
| 0.044 | 0.01 | 0.044 | Cholesterol ester transfer protein antagonist | 0.039 0.014 CID_154699584 | ||
| 0.099 | 0.067 | 0.099 | Nav1.1 sodium channel blocker | |||
| 0.083 | 0.051 | 0.083 | Topoisomerase II alpha inhibitor | |||
| 0.081 | 0.049 | 0.081 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.05 | 0.019 | 0.05 | Thymidine kinase inhibitor | |||
| 0.049 | 0.018 | 0.049 | Acid-sensing ion channel blocker | |||
| 0.062 | 0.032 | 0.062 | Acyl-CoA dehydrogenase inhibitor | |||
| 0.039 | 0.009 | 0.039 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.036 | 0.006 | 0.036 | Hedgehog signaling activator | |||
| 0.131 | 0.103 | 0.131 | GABA C receptor rho-2 antagonist | |||
| 0.113 | 0.085 | 0.113 | Cathepsin H inhibitor | |||
| 0.113 | 0.085 | 0.113 | Toll-Like receptor 2 antagonist | |||
| 0.057 | 0.029 | 0.057 | Aconitate hydratase inhibitor | |||
| 0.055 | 0.027 | 0.055 | Phosphorylase inhibitor | |||
| 0.035 | 0.007 | 0.035 | Thymidine kinase (Herpes simplex virus 1) inhibitor | |||
| 0.077 | 0.05 | 0.077 | GABA aminotransferase inhibitor | |||
| 0.102 | 0.075 | 0.102 | Mucolytic | |||
| 0.18 | 0.154 | 0.18 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.034 | 0.008 | 0.034 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.094 | 0.069 | 0.094 | Carbonic anhydrase III inhibitor | |||
| 0.115 | 0.09 | 0.155 | Nav1.2 sodium channel blocker | 0.155 0.054 CID_154699584 | CID_154699584 | |
| 0.043 | 0.018 | 0.043 | Glutamate (mGluR3) antagonist | |||
| 0.056 | 0.032 | 0.056 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.046 | 0.021 | 0.046 | Sphingosine kinase 1 inhibitor | |||
| 0.053 | 0.029 | 0.053 | Squalene epoxidase inhibitor | |||
| 0.029 | 0.005 | 0.029 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.034 | 0.01 | 0.034 | Prostaglandin EP2 agonist | |||
| 0.037 | 0.013 | 0.037 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.045 | 0.021 | 0.045 | Phenylethanolamine N methyltransferase inhibitor | |||
| 0.047 | 0.024 | 0.052 | Guanylate cyclase inhibitor | 0.052 0.019 CID_154699584 | CID_154699584 | |
| 0.064 | 0.041 | 0.064 | Adrenaline uptake inhibitor | |||
| 0.114 | 0.091 | 0.114 | Antibacterial (Helicobacter pylori) | 0.113 0.092 CID_154699584 | ||
| 0.039 | 0.016 | 0.039 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.08 | 0.057 | 0.08 | Carbonic anhydrase VI inhibitor | |||
| 0.045 | 0.022 | 0.045 | NMDA receptor subunit 3A antagonist | |||
| 0.103 | 0.081 | 0.183 | Acetylcholine release stimulant | 0.183 0.005 CID_154699584 | CID_154699584 | |
| 0.072 | 0.05 | 0.072 | Telomerase inhibitor | |||
| 0.124 | 0.102 | 0.124 | Acetylcholine M1 receptor antagonist | |||
| 0.055 | 0.033 | 0.055 | 5 Hydroxytryptamine 2 agonist | |||
| 0.041 | 0.019 | 0.041 | Retinoid X alpha receptor agonist | |||
| 0.044 | 0.023 | 0.044 | Kainate receptor agonist | |||
| 0.033 | 0.012 | 0.033 | Purinergic P2Y15 antagonist | |||
| 0.069 | 0.049 | 0.069 | Protein kinase C beta inhibitor | |||
| 0.072 | 0.052 | 0.072 | Glutamate decarboxylase inhibitor | |||
| 0.025 | 0.005 | 0.025 | Antibiotic Anthracycline-like | |||
| 0.088 | 0.069 | 0.088 | ABCA1 expression enhancer | |||
| 0.024 | 0.005 | 0.024 | NMDA receptor phencyclidine site antagonist | |||
| 0.036 | 0.017 | 0.036 | ATP citrate lysase inhibitor | |||
| 0.023 | 0.004 | 0.023 | Thromboxane agonist | |||
| 0.074 | 0.055 | 0.074 | Analgesic, opioid | |||
| 0.032 | 0.013 | 0.032 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.061 | 0.042 | 0.061 | Purinergic P2X1 antagonist | |||
| 0.029 | 0.012 | 0.029 | Sodium/glucose cotransporter inhibitor | |||
| 0.037 | 0.019 | 0.037 | HMG CoA reductase inhibitor | |||
| 0.048 | 0.03 | 0.048 | Thymidylate synthase inhibitor | |||
| 0.034 | 0.018 | 0.034 | Prostaglandin agonist | |||
| 0.116 | 0.101 | 0.116 | Neurotrophic factor | |||
| 0.135 | 0.12 | 0.135 | Amyloid beta aggregation inhibitor | |||
| 0.069 | 0.055 | 0.069 | Aminopeptidase I inhibitor | |||
| 0.067 | 0.053 | 0.067 | Histidine decarboxylase inhibitor | |||
| 0.034 | 0.021 | 0.034 | Glucocorticoid antagonist | |||
| 0.025 | 0.012 | 0.025 | Adenosine kinase inhibitor | |||
| 0.032 | 0.019 | 0.032 | Prostaglandin D2 agonist | |||
| 0.046 | 0.034 | 0.046 | Potassium channel Kv1.3 blocker | |||
| 0.049 | 0.037 | 0.049 | CD45 antagonist | |||
| 0.054 | 0.042 | 0.054 | 5 Hydroxytryptamine 7 agonist | |||
| 0.062 | 0.05 | 0.067 | Interferon inducer | 0.067 0.04 CID_154699584 | CID_154699584 | |
| 0.02 | 0.008 | 0.02 | Telomerase stimulant | |||
| 0.093 | 0.082 | 0.093 | Beta glucuronidase inhibitor | |||
| 0.024 | 0.013 | 0.024 | Prostaglandin F2 alpha agonist | |||
| 0.082 | 0.071 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.034 | 0.024 | 0.034 | Fumarate hydratase inhibitor | |||
| 0.034 | 0.024 | 0.034 | Tubulin agonist | |||
| 0.042 | 0.032 | 0.042 | GABA B receptor antagonist | |||
| 0.165 | 0.155 | 0.165 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.112 | 0.102 | 0.112 | Protein kinase C nu inhibitor | |||
| 0.05 | 0.04 | 0.05 | Opioid agonist | |||
| 0.065 | 0.056 | 0.065 | Exportin-1 inhibitor | |||
| 0.044 | 0.036 | 0.044 | Adenosine deaminase inhibitor | |||
| 0.112 | 0.105 | 0.112 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.067 | 0.059 | 0.067 | Porphobilinogen synthase inhibitor | |||
| 0.048 | 0.042 | 0.048 | Protein 50S ribosomal subunit inhibitor | |||
| 0.041 | 0.035 | 0.041 | 5 Hydroxytryptamine 2C agonist | |||
| 0.036 | 0.029 | 0.036 | Farnesoid X receptor agonist | |||
| 0.039 | 0.033 | 0.039 | Plasmepsin II inhibitor | |||
| 0.034 | 0.029 | 0.034 | 5-Alpha-reductase inhibitor | |||
| 0.035 | 0.03 | 0.035 | Delayed rectifier potassium channel blocker | |||
| 0.037 | 0.031 | 0.037 | GABA uptake inhibitor | |||
| 0.032 | 0.028 | 0.032 | Retinoid X receptor agonist | |||
| 0.045 | 0.042 | 0.045 | HCV NS3/NS4A protease inhibitor | |||
| 0.02 | 0.017 | 0.093 | Estrone sulfatase inhibitor | 0.093 0.005 CID_154699584 | CID_154699584 | |
| 0.041 | 0.037 | 0.041 | Heme oxygenase inhibitor | |||
| 0.039 | 0.036 | 0.039 | NMDA receptor subunit 3B antagonist | |||
| 0.031 | 0.028 | 0.031 | RNA-directed RNA polymerase inhibitor | |||
| 0.149 | 0.146 | 0.149 | Free radical scavenger | |||
| 0.113 | 0.11 | 0.205 | Cell wall synthesis inhibitor | 0.205 0.028 CID_154699584 | CID_154699584 | |
| 0.075 | 0.073 | 0.075 | Acetylcholine agonist | |||
| 0.016 | 0.014 | 0.016 | Progesterone agonist | |||
| 0.053 | 0.051 | 0.053 | Pregnane X receptor antagonist | |||
| 0.054 | 0.052 | 0.054 | Heat shock protein 90 beta antagonist | |||
| 0.025 | 0.023 | 0.26 | NMDA 2D receptor antagonist | 0.26 0.002 CID_154699584 | CID_154699584 | |
| 0.117 | 0.115 | 0.117 | Insulin secretagoues | |||
| 0.029 | 0.027 | 0.029 | Vasopressin 2 antagonist | |||
| 0.025 | 0.024 | 0.025 | Liver X receptor beta antagonist | |||
| 0.048 | 0.05 | 0.086 | Heparanase inhibitor | 0.086 0.005 CID_154699584 | CID_154699584 | |
| 0.016 | 0.037 | 0.023 | Dopamine D1 agonist | 0.023 0.015 CID_154699584 | CID_154699584 | |
| 0.07 | 0.094 | 0.124 | Aminopeptidase B inhibitor | 0.124 0.05 CID_154699584 | CID_154699584 | |
| 0.04 | 0.069 | 0.568 | NMDA 2B receptor antagonist | 0.568 0.003 CID_154699584 | CID_154699584 | |
| 0.126 | 0.16 | 0.154 | Anticonvulsant | 0.154 0.125 CID_154699584 | CID_154699584 | |
| 0.054 | 0.098 | 0.197 | CDC25A inhibitor | 0.197 0.007 CID_154699584 | CID_154699584 | |
| 0.016 | 0.064 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.015 CID_154699584 | CID_154699584 | |
| 0.044 | 0.093 | 0.086 | Catalase inhibitor | 0.086 0.044 CID_154699584 | CID_154699584 | |
| 0.034 | 0.084 | 0.26 | HIV-1 integrase (Strand Transfer) inhibitor | 0.26 0.006 CID_154699584 | CID_154699584 | |
| 0.034 | 0.091 | 0.339 | Selectin antagonist | 0.339 0.004 CID_154699584 | CID_154699584 | |
| 0.02 | 0.079 | 0.057 | Dopamine D2 agonist | 0.057 0.022 CID_154699584 | CID_154699584 | |
| 0.099 | 0.16 | 0.712 | Angiogenesis stimulant | 0.712 0.004 CID_154699584 | CID_154699584 | |
| 0.041 | 0.121 | 0.061 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.051 CID_154699584 | CID_154699584 | |
| 0.014 | 0.094 | 0.033 | 1,3-Beta-glucan synthase inhibitor | 0.033 0.008 CID_154699584 | CID_154699584 | |
| 0.04 | 0.121 | 0.104 | Adenine nucleotide translocase inhibitor | 0.104 0.004 CID_154699584 | CID_154699584 | |
| 0.036 | 0.125 | 0.091 | Carbonic anhydrase XIII inhibitor | 0.091 0.043 CID_154699584 | CID_154699584 | |
| 0.034 | 0.123 | 0.202 | HIV-1 integrase (3'-Processing) inhibitor | 0.202 0.009 CID_154699584 | CID_154699584 | |
| 0.075 | 0.167 | 0.204 | Thrombolytic | 0.204 0.05 CID_154699584 | CID_154699584 | |
| 0.147 | 0.244 | 0.612 | Angiogenesis inhibitor | 0.612 0.015 CID_154699584 | CID_154699584 | |
| 0.088 | 0.215 | 0.264 | Hemostatic | 0.264 0.02 CID_154699584 | CID_154699584 | |
| 0.085 | 0.213 | 0.273 | Platelet adhesion inhibitor | 0.273 0.042 CID_154699584 | CID_154699584 | |
| 0.016 | 0.166 | 0.045 | Purinergic P2Y2 antagonist | 0.045 0.013 CID_154699584 | CID_154699584 | |
| 0.016 | 0.166 | 0.046 | Toll-Like receptor 4 agonist | 0.046 0.004 CID_154699584 | CID_154699584 | |
| 0.036 | 0.191 | 0.076 | HIV-1 integrase inhibitor | 0.076 0.041 CID_154699584 | CID_154699584 | |
| 0.022 | 0.176 | 0.072 | Carbonic anhydrase V inhibitor | 0.072 0.041 CID_154699584 | CID_154699584 | |
| 0.041 | 0.242 | 0.171 | Cell adhesion molecule inhibitor | 0.171 0.012 CID_154699584 | CID_154699584 | |
| 0.04 | 0.282 | 0.212 | Multidrug resistance-associated protein 1 inhibitor | 0.212 0.008 CID_154699584 | CID_154699584 | |
| 0.018 | 0.269 | 0.076 | Neuraminidase (influenza) inhibitor | 0.076 0.028 CID_154699584 | CID_154699584 | |
| 0.048 | 0.301 | 0.142 | Cell adhesion inhibitor | 0.142 0.051 CID_154699584 | CID_154699584 | |
| 0.012 | 0.374 | 0.61 | Cholecystokinin B agonist | 0.61 0.002 CID_154699584 | CID_154699584 | |
| 0.022 | 0.514 | 0.353 | Dual specificity phosphatase 3 inhibitor | 0.353 0.02 CID_154699584 | CID_154699584 | |
| 0.025 | 0.52 | 0.117 | Nav1.4 sodium channel blocker | 0.117 0.055 CID_154699584 | CID_154699584 | |
| 0.023 | 0.53 | 0.353 | Dual specificity phosphatase inhibitor | 0.353 0.02 CID_154699584 | CID_154699584 | |
| 0.003 | 0.547 | 0.181 | Cholecystokinin B antagonist | 0.181 0.004 CID_154699584 | CID_154699584 | |
| 0.014 | 0.603 | 0.147 | Factor IXa inhibitor | 0.147 0.004 CID_154699584 | CID_154699584 | |
| 0.014 | 0.62 | 0.545 | Anticoagulant | 0.545 0.008 CID_154699584 | CID_154699584 | |
| 0.003 | 0.654 | 0.604 | Cholecystokinin agonist | 0.604 0.002 CID_154699584 | CID_154699584 | |
| 0.003 | 0.668 | 0.184 | Cholecystokinin antagonist | 0.184 0.005 CID_154699584 | CID_154699584 | |
| 0.003 | 0.675 | 0.246 | Cholecystokinin A antagonist | 0.246 0.004 CID_154699584 | CID_154699584 | |
| 0.003 | 0.74 | 0.374 | Cholecystokinin A agonist | 0.374 0.002 CID_154699584 | CID_154699584 | |
| 0.004 | 0.879 | 0.068 | Thrombin inhibitor | 0.068 0.058 CID_154699584 | CID_154699584 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |